Search
Close this search box.

Press Releases

ESR Secures US$850 Million to Accelerate Long-term Growth

Additional equity support from existing shareholders underscores confidence in ESR’s strategy and execution momentum Capital to fund growth initiatives across ESR’s logistics real estate and data centres platforms in APAC Builds on US$2 billion of net proceeds from portfolio simplification and capital recycling SINGAPORE – Media OutReach Newswire – 9 April 2026 – ESR, an Asia-Pacific (“APAC”) […]

CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”), of the important April 21, 2026 lead plaintiff deadline. SO WHAT: If you purchased Corcept common stock […]

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – NKTR

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nektar Therapeutics (NASDAQ: NKTR) between February 26, 2025 and December 15, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Nektar securities during […]

NAVAN DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Navan, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 24 Deadline in Securities Class Action – NAVN

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Navan, Inc. (NASDAQ: NAVN) pursuant and/or traceable to the Registration Statement and Prospectus (collectively, the “Offering Documents”) issued in connection with Navan’s October 2025 initial public offering (the “IPO”), of the important April […]